, and Alex D. Washburne. Using influenza surveillance networks
to estimate state-specific prevalence of sars-cov-2 in the united states. Science Translational Medicine,
2020.
[7] Fiona P. Havers, Carrie Reed, Travis W. Lim, Joel M. Montgomery, John D. Klena, Aron J. Hall, Ali-
ciaM.Fry, DeborahL.Cannon, Cheng-FengChiang, AridthGibbons, InnaKrapiunaya, MariaMorales-
Betoulle, Katherine Roguski, Mohammed Rasheed, Brandi Freeman, Sandra Lester, Lisa Mills, Darin S.
Carroll,S.MichelleOwen,JeffreyA.Johnson,VeraA.Semenova,,JaradSchiffer,andNatalieP.Thorn-
burg. Seroprevalence of antibodies to sars-cov-2 in six sites in the united states, march 23-may 3, 2020.
medRxiv, 2020.
9https://covidtracking.com/data/
10https://www.census.gov/newsroom/press-kits/2019/national-state-estimates.html
8
